Brief: Nuvation Bio Q2 EPS USD -1.89
05/08/2024 13:00
Aug 05 (Reuters) - Nuvation Bio Q2 net income USD -462.492 million. * Q2 pretax profit USD -462.492 million * Q2 operating profit USD -470.385 million * Q2 operating expenses USD 470.473 million
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth